Tue, 01/26/2021 - 12:02
During a short period of time, our society has seen a rapid increase in the interest and availability of cannabidiol (CBD) products and other products derived from cannabis. However, we still have a limited understanding of the safety profile of CBD…Amy P. Abernethy
As the Principal Deputy Commissioner of Food and Drugs, Dr. Amy P. Abernethy, M.D., Ph.D., helps oversee the agency’s day-to-day functioning and directs special and high-priority initiatives that cut across offices overseeing FDA’s regulation of drugs, medical devices, tobacco and food. As of April 2019, Abernethy is also the Acting Chief Information Officer (CIO), responsible for oversight of the trans-agency technical and data-focused vision plus its implementation.
Tue, 01/26/2021 - 12:02